HAWPF (Haw Par) EBIT: $220.2 Mil (TTM As of Dec. 2025)


HAWPF Haw Par Corp Ltd HAWPF
95 GF Score
Price $12.00
GF Value $8.79
! 3 Warning Signs
View Full Analysis

What is Haw Par EBIT?

Haw Par HAWPF 95 EBIT is $220.2 Mil as of Dec. 2025. GuruFocus rates HAWPF with a GF Score™ of 95/100 and a GF Value™ of $8.79. The stock has 3 warning signs investors should review.

Haw Par's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was $101.0 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was $220.2 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Haw Par's annualized ROC % for the quarter that ended in Dec. 2025 was 32.47%. Haw Par's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 527.22%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Haw Par's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -48.47%.


Haw Par  (OTCPK:HAWPF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Haw Par's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=52.482 * ( 1 - 6.42% )/( (169.206 + 133.346)/ 2 )
=49.1126556/151.276
=32.47 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3280.937 - 70.44 - ( 3081.305 - max(0, 96.941 - 3138.232+3081.305))
=169.206

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=3422.876 - 62.964 - ( 3240.359 - max(0, 62.964 - 3289.53+3240.359))
=133.346

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Haw Par's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=202.026/( ( (37.917 + max(-13.513, 0)) + (38.721 + max(-19.134, 0)) )/ 2 )
=202.026/( ( 37.917 + 38.721 )/ 2 )
=202.026/38.319
=527.22 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(39.364 + 17.212 + 0.35100000000011) - (70.44 + 0 + 0)
=-13.513

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(26.225 + 16.926 + 0.67900000000009) - (62.964 + 0 + 0)
=-19.134

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Haw Par's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=220.151/-454.242
=-48.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Haw Par EBIT Related Terms


Haw Par EBIT Historical Data

* Premium members only.

The historical data trend for Haw Par's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haw Par EBIT Chart

Haw Par Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 85.23 117.99 173.37 183.80 219.39

Haw Par Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.42 96.32 87.39 119.14 101.01

HAWPF vs LLY, JNJ, ABBV: EBIT Comparison

For the Drug Manufacturers - General subindustry, Haw Par's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Haw Par EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haw Par's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Haw Par's EV-to-EBIT falls into.


HAWPF
95GF Score
Haw Par Corp Ltd HAWPF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Haw Par EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $220.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $220.2 Mil mean?
Haw Par (HAWPF) has a EBIT of $220.2 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Haw Par.
Is Haw Par's EBIT too high?
Haw Par's current EBIT is $220.2 Mil. Overall, Haw Par has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Haw Par's EBIT compare to LLY and JNJ?
Haw Par's EBIT of $220.2 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Haw Par. Haw Par's current EBIT is $220.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haw Par stock overvalued right now?
Haw Par (HAWPF) has a current EBIT of $220.2 Mil. The stock's GF Value™ is $8.79, compared to a current price of $12.00 — trading 36.5% above its estimated fair value. The current EBIT is $220.2 Mil. Haw Par's overall GF Score™ is 95/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Haw Par (HAWPF), the current EBIT is $220.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Haw Par (HAWPF) Overvalued in 2026?

Based on GuruFocus' analysis, Haw Par stock appears to be overvalued. The current stock price of $12.00 is trading 36.5% above its estimated GF Value™ of $8.79.

Key valuation signals for HAWPF:

  • EBIT: $220.2 Mil
  • GF Value™: $8.79 vs. price of $12.00 (36.5% above fair value)
  • GF Score™: 95/100 with 3 warning signs

No single metric tells the full story. See the HAWPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Haw Par Business Description

Other Exchanges H02:SingaporeH4V:Germany
Address 401 Commonwealth Drive, No. 03-03 Haw Par Technocentre, Singapore, SGP, 149598
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, Property segment, and Leisure segment. The company generates the majority of its revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates key revenue from the other ASEAN and other Asian countries.
95GF Score

Get the complete analysis for HAWPF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.00
Price
$8.79
GF Value